ICON plc

ICON plc is a global provider of clinical, consulting, and commercial services, catering to sectors such as Biotech, Government and Public Health, Medical Device, and Pharmaceuticals. The company offers decentralised clinical trial solutions with end-to-end services, operational models, and technology to deliver customized solutions. ICON’s Real World Intelligence® leverages real-world data to drive effective outcomes and achieve regulatory authorization. The company has extensive experience in therapeutic areas including Cardiovascular, Central Nervous System, Endocrine & Metabolic Disorders, Infectious Diseases, Internal Medicine & Immunology, and Oncology. Recognized as one of the world’s leading Contract Research Organisations, ICON has received numerous high-profile industry awards. ICON’s mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. With operations in over 40 countries and more than 41,150 employees, ICON provides laboratory services through its global Central Laboratories, Bioanalytical Laboratory, and Specialty Laboratories. ICON’s therapeutic experts regularly contribute to industry publications and thought leadership content. The company offers specialized services to assist pharmaceutical, biotechnology, and medical device companies in bringing new drugs and devices to market faster. ICON has a dedicated resource center for Investigators and Study Coordinators using ICON Central Laboratories’ services and has developed 18 of the world’s top 20 best-selling drugs. ICON’s early clinical solutions include services such as Clinical Pharmacology, Pharmacodynamic Models, and Bioanalytical and Biomarker Laboratories. Their Medical Imaging services provide end-to-end integrated solutions based on imaging biomarkers. ICON’s Accellacare is a global site network that combines proprietary site networks and healthcare alliance sites to provide greater access to patients and multi-specialty physicians. The company has expertise in managing complex clinical trials in therapeutic areas like Oncology, Cardiovascular, Central Nervous System, and Infectious Diseases. ICON’s consulting services cover asset development, commercial positioning, and regulatory affairs to navigate from molecule to medicine. The company focuses on patient-centric trials and real-world, real-time data to transform recruitment and improve trial outcomes. ICON’s FIRECREST digital solutions enhance efficiency in clinical trials by driving site performance. Notably, ICON has been involved in the development of vaccines, including the world’s first approved vaccine for COVID-19.